Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Name: Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Published: 2011
License: Public Domain

City of Hope Medical Center · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

antineoplastic-agents breast-neoplasms geriatric-assessment pharmacokinetics toxicity

breast neoplasms, her2/neu positive, geriatric health services, her2 protein, human, antineoplastic agents, combined, geriatric assessment, pharmacokinetics, toxicity, patient adherence, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Related documents